Alnylam Pharmaceuticals Ownership | Who Owns Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals Ownership Summary
Alnylam Pharmaceuticals is owned by 95.66% institutional investors, 0.42% insiders, and 3.92% retail investors. Capital world investors is the largest institutional shareholder, holding 11.87% of ALNY shares. Capital Group Growth Fnd of Amer Comp is the top mutual fund, with 8.45% of its assets in Alnylam Pharmaceuticals shares.
ALNY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alnylam Pharmaceuticals | 95.66% | 0.42% | 3.92% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Capital world investors | 14.97M | 11.87% | $3.64B |
| Vanguard group | 12.51M | 9.92% | $3.04B |
| Fmr | 12.16M | 9.64% | $2.96B |
| Blackrock | 9.55M | 7.57% | $2.32B |
| Wellington management group llp | 6.21M | 4.92% | $1.51B |
| Baillie gifford | 6.03M | 4.78% | $1.47B |
| Capital investors | 3.89M | 3.08% | $945.65M |
| Dodge & cox | 3.78M | 3.00% | $918.58M |
| State street | 3.53M | 2.80% | $858.97M |
| Price t rowe associates inc /md/ | 3.49M | 2.77% | $847.59M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bridger management | 37.02K | 4.63% | $9.00M |
| Bellevue group | 919.83K | 3.63% | $223.52M |
| Eagle health investments lp | 76.26K | 3.25% | $18.53M |
| Casdin capital | 170.00K | 3.15% | $41.31M |
| Rosenblum silverman sutton s f inc /ca | 35.20K | 2.29% | $8.55M |
| 683 capital management | 122.90K | 2.26% | $29.86M |
| Antipodes partners | 238.75K | 2.16% | $59.43M |
| Silverarc capital management | 36.00K | 2.06% | $8.75M |
| Rhenman & partners asset management ab | 85.50K | 1.99% | $20.78M |
| Artia global partners lp | 35.00K | 1.64% | $8.51M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 2.30M | 0.08% | 2.30M |
| Fmr | 12.16M | 0.19% | 2.20M |
| Capital world investors | 14.97M | 0.59% | 2.18M |
| Orbis allan gray | 721.05K | 1.09% | 721.05K |
| Blackrock | 9.55M | 0.05% | 522.66K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 6.21M | 0.27% | -998.53K |
| Baillie gifford | 6.03M | 1.14% | -590.92K |
| Logos global management lp | - | - | -500.00K |
| Deep track capital, lp | - | - | -500.00K |
| Avoro capital advisors | - | - | -400.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 2.30M | 0.08% | 2.30M | $558.12M |
| Orbis allan gray | 721.05K | 1.09% | 721.05K | $175.22M |
| Adage capital partners gp | 254.00K | 0.11% | 254.00K | $61.72M |
| Frontier capital management | 168.44K | 0.41% | 168.44K | $40.93M |
| Bank of america corp /de/ | 83.50K | 0.00% | 83.50K | $20.29M |
Sold Out
| Holder | Change |
|---|---|
| Johnson financial group | -1.00 |
| Financial gravity asset management | -1.00 |
| Harbor investment advisory | -1.00 |
| Cva family office | -3.00 |
| Abound wealth management | -3.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 599 | 4.17% | 123,006,457 | 2.58% | 95 | 1.07% | 320 | 10.73% | 170 | 4.94% |
| Jun 30, 2024 | 571 | 3.25% | 119,905,127 | 6.57% | 95 | 1.19% | 286 | 4.38% | 162 | 3.18% |
| Mar 31, 2024 | 553 | 3.56% | 112,509,382 | -3.80% | 89 | 1.02% | 274 | 3.40% | 157 | 1.95% |
| Dec 31, 2023 | 534 | 8.32% | 116,949,479 | 0.55% | 93 | 1.09% | 265 | 28.02% | 154 | -7.23% |
| Sep 30, 2023 | 493 | 0.20% | 116,310,429 | -1.58% | 92 | 1.03% | 207 | -2.82% | 166 | 7.10% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Capital Group Growth Fnd of Amer Comp | 10.84M | 8.45% | 1.60M |
| American Funds Growth Fund of Amer A | 10.84M | 8.45% | 1.60M |
| Vanguard Total Stock Mkt Idx Inv | 4.06M | 3.14% | -15.03K |
| Vanguard Health Care Inv | 4.02M | 3.12% | -1.01M |
| Capital Group New Perspective Comp | 3.71M | 2.89% | 245.21K |
| American Funds New Perspective A | 3.71M | 2.89% | 245.21K |
| Capital Group AMCAP Composite | 3.07M | 2.39% | 443.45K |
| VA CollegeAmerica Amcap 529A | 3.07M | 2.39% | 443.45K |
| Vanguard Mid Cap Index Institutional | 2.72M | 2.11% | 4.91K |
| Dodge & Cox Stock I | 2.32M | 1.80% | -29.10K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 12, 2024 | Garg Pushkal | CMO & EVP Dev & Med Affairs | Sell | $106.53K |
| Dec 12, 2024 | Garg Pushkal | CMO & EVP Dev & Med Affairs | Sell | $195.81K |
| Dec 12, 2024 | Garg Pushkal | CMO & EVP Dev & Med Affairs | Sell | $29.95K |
| Dec 12, 2024 | Garg Pushkal | CMO & EVP Dev & Med Affairs | Sell | $46.31K |
| Dec 12, 2024 | Garg Pushkal | CMO & EVP Dev & Med Affairs | Sell | $25.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 36 |
| 2024 Q3 | - | 16 |
| 2024 Q2 | - | 67 |
| 2024 Q1 | - | 46 |
| 2023 Q4 | - | 1 |
ALNY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools